2nd Circ. Nixes $1.3B Asthma Drug Suit V. AstraZeneca
Verus Pharmaceuticals Inc.'s contract with AstraZeneca merely required it to try to get regulatory approval in the U.S. for a drug called budesonide — it did not require the defendant to succeed, a three-judge panel ruled.
The plaintiff has for two years tried in vain to convince courts that AstraZeneca illegally dumped...
To view the full article, register now.